Morpholino

MO1-csde1

ID

ZDB-MRPHLNO-260126-2

Name

MO1-csde1

Previous Names

None

Target

csde1 (1)

Sequence

5' - GGGTCAAAACTCATCTTGTTCTGTT - 3'

Disclaimer

Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.

Note

None

Genome Resources

None

Target Location

Genomic Features

No data available

Expression

Gene expression in Wild Types + MO1-csde1

No data available

Phenotype

Phenotype resulting from MO1-csde1

Phenotype	Fish	Figures
beta-catenin binding decreased efficacy, abnormal	TU + MO1-csde1	Fig. 5. from Li et al., 2023
endothelial cell Ab17-ctnnb labeling decreased amount, abnormal	y1Tg/y1Tg + MO1-csde1	Fig. 5. from Li et al., 2023
endothelial cell lef1 expression decreased amount, abnormal	s843Tg/s843Tg + MO1-csde1	Fig. 3. from Li et al., 2023
endothelial cell tcf3a expression decreased amount, abnormal	s843Tg/s843Tg + MO1-csde1	Fig. 3. from Li et al., 2023
endothelial cell ccnd1 expression decreased amount, abnormal	s843Tg/s843Tg + MO1-csde1	Fig. 3. , Fig. 6. from Li et al., 2023
endothelial cell myb expression decreased amount, abnormal	s843Tg/s843Tg + MO1-csde1	Fig. 6. from Li et al., 2023
endothelial cell cdk2 expression decreased amount, abnormal	s843Tg/s843Tg + MO1-csde1	Fig. 3. , Fig. 6. from Li et al., 2023
endothelial cell runx1 expression decreased amount, abnormal	s843Tg/s843Tg + MO1-csde1	Fig. 6. from Li et al., 2023
endothelial cell axin2 expression decreased amount, abnormal	s843Tg/s843Tg + MO1-csde1	Fig. 3. , Fig. 6. from Li et al., 2023
endothelial cell beta-catenin binding decreased occurrence, abnormal	y1Tg/y1Tg + MO1-csde1	Fig. 5. from Li et al., 2023
hematopoietic multipotent progenitor cell runx1 expression decreased amount, abnormal	TU + MO1-csde1	Fig. 1. from Li et al., 2023
hematopoietic multipotent progenitor cell myb expression decreased amount, abnormal	TU + MO1-csde1	Fig. 1. from Li et al., 2023
hematopoietic multipotent progenitor cell mRNA binding decreased process quality, abnormal	y1Tg/y1Tg + MO1-csde1	Fig. 5. from Li et al., 2023
trunk ab8-ctnnb labeling decreased amount, abnormal	TU + MO1-csde1	Fig. 5. from Li et al., 2023
ventral wall of dorsal aorta hematopoietic multipotent progenitor cell runx1 expression decreased amount, abnormal	TU + MO1-csde1	Fig. 1. from Li et al., 2023
ventral wall of dorsal aorta hematopoietic multipotent progenitor cell myb expression decreased amount, abnormal	TU + MO1-csde1	Fig. 1. from Li et al., 2023

Phenotype of all Fish created by or utilizing MO1-csde1

Phenotype	Fish	Conditions	Figures
endothelial cell runx1 expression decreased amount, abnormal	s843Tg/s843Tg + MO1-csde1	standard conditions	Fig. 6. from Li et al., 2023
endothelial cell tcf3a expression decreased amount, abnormal	s843Tg/s843Tg + MO1-csde1	standard conditions	Fig. 3. from Li et al., 2023
endothelial cell cdk2 expression decreased amount, abnormal	s843Tg/s843Tg + MO1-csde1	standard conditions	Fig. 3. , Fig. 6. from Li et al., 2023
endothelial cell myb expression decreased amount, abnormal	s843Tg/s843Tg + MO1-csde1	standard conditions	Fig. 6. from Li et al., 2023
endothelial cell axin2 expression decreased amount, abnormal	s843Tg/s843Tg + MO1-csde1	standard conditions	Fig. 3. , Fig. 6. from Li et al., 2023
endothelial cell ccnd1 expression decreased amount, abnormal	s843Tg/s843Tg + MO1-csde1	standard conditions	Fig. 3. , Fig. 6. from Li et al., 2023
endothelial cell lef1 expression decreased amount, abnormal	s843Tg/s843Tg + MO1-csde1	standard conditions	Fig. 3. from Li et al., 2023
endothelial cell beta-catenin binding decreased occurrence, abnormal	y1Tg/y1Tg + MO1-csde1	standard conditions	Fig. 5. from Li et al., 2023
endothelial cell Ab17-ctnnb labeling decreased amount, abnormal	y1Tg/y1Tg + MO1-csde1	standard conditions	Fig. 5. from Li et al., 2023
hematopoietic multipotent progenitor cell mRNA binding decreased process quality, abnormal	y1Tg/y1Tg + MO1-csde1	standard conditions	Fig. 5. from Li et al., 2023
ventral wall of dorsal aorta hematopoietic multipotent progenitor cell runx1 expression decreased amount, abnormal	TU + MO1-csde1	standard conditions	Fig. 1. from Li et al., 2023
hematopoietic multipotent progenitor cell runx1 expression decreased amount, abnormal	TU + MO1-csde1	standard conditions	Fig. 1. from Li et al., 2023
beta-catenin binding decreased efficacy, abnormal	TU + MO1-csde1	standard conditions	Fig. 5. from Li et al., 2023
trunk ab8-ctnnb labeling decreased amount, abnormal	TU + MO1-csde1	standard conditions	Fig. 5. from Li et al., 2023
hematopoietic multipotent progenitor cell myb expression decreased amount, abnormal	TU + MO1-csde1	standard conditions	Fig. 1. from Li et al., 2023
ventral wall of dorsal aorta hematopoietic multipotent progenitor cell myb expression decreased amount, abnormal	TU + MO1-csde1	standard conditions	Fig. 1. from Li et al., 2023
ventral wall of dorsal aorta hematopoietic multipotent progenitor cell EGFP expression decreased amount, abnormal	zf169Tg/zf169Tg + MO1-csde1	standard conditions	Fig. 6. from Li et al., 2023

Citations